Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Pharmacoeconomic analysis of cost-benefit in evaluating the effectiveness of treatment for epilepsy in adults

https://doi.org/10.14412/2074-2711-2010-88

Full Text:

Abstract

The investigation evaluated the clinicoeconomic benefits of epilepsy therapy performed by a district neurologist versus an epileptologist in the outpatient setting. The index «cost-benefit» was calculated for different types of epileptic seizures in employed and unemployed patients before and after therapy optimization. Even if there was a considerable increase in direct costs after correction of antiepileptic therapy, the cost of patient management was shown to decrease by 2-3 times on average irrespective of the type of a seizure.

References

1. <div><p>Карлов В.А. Эпилепсия. М.: Медицина, 1990.</p><p>Devinsky O., Westbrook L., Cramer J. et al. Risk factors for poor health-related quality of life in adolescents with epilepsy. Epilepsia 1999; 40: 1715-20.</p><p>Brodie M.J., Mohanraj R. Response to treatment in newly diagnosed epilepsy. Epilepsia 2003; 44(Suppl. 9): 14.</p><p>Гехт А.Б. Эпидемиология и фармакоэко- номические аспекты эпилепсии. Журн. неврол. и психиатр. им. С.С.Корсакова 2005; 105(8): 63-5.</p><p>Мухин К.Ю., Петрухин А.С. Идиопатические формы эпилепсии: систематика, диагностика, терапия. М.: Арт-Бизнес-центр, 2000.</p><p>Власов П.Н. Алгоритмы диагностики и терапии эпилепсии у взрослых в поликлинических условиях. Фарматека 2006; 7: 96-104.</p></div><br />


For citation:


Vlasov P.N., Orekhova N.V., Leonova M.V. Pharmacoeconomic analysis of cost-benefit in evaluating the effectiveness of treatment for epilepsy in adults. Neurology, Neuropsychiatry, Psychosomatics. 2010;2(2):66-70. (In Russ.) https://doi.org/10.14412/2074-2711-2010-88

Views: 368


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)